Last reviewed · How we verify

NCT03132818: SEXODON

Impact of the Assumption in Charge of Medical Aid to the Procreation With Donation of Gametes on the Sexuality of the Couple

Withdrawn Last updated 17 July 2020
What this trial tests

trial testing To evaluate the prevalence of sexual disorders in patients receiving AMP in Sexuality. Withdrawn.

Timeline
20 July 2017
Primary endpoint
20 February 2019
20 February 2019

Quick facts

Lead sponsorCentre Hospitalier Universitaire, Amiens
StatusWithdrawn
Study typeOBSERVATIONAL
Start date20 July 2017
Primary completion20 February 2019
Estimated completion20 February 2019
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Universitaire, Amiens

Who can join

18 and older, any sex, with Sexuality. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Sexual disorders associated with medical aid for procreation have already been demonstrated in several studies. However, few of them are interested in the problem of patients in charge of donating gametes, and if studied, it is often restricted to donating sperm to a small number of patients. For this reason, it would be interesting to study the impact of the intake and in charge and the treatments of the Medical Aid to the Procreation on this population of patients (including the patients treated in donation of sperm but also Those supported in oocyte donation)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Sexuality

Currently open trials in the same condition.

Other Centre Hospitalier Universitaire, Amiens trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03132818.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing